Investment Rating - The investment rating for the company is "Outperform the Market" [4][11][28] Core Views - The company achieved a net profit attributable to shareholders of 246 million yuan in 2024, representing a year-on-year growth of 27%. In the first quarter of 2025, the net profit reached 81.4 million yuan, a significant increase of 52% [1][13] - The company’s revenue for 2024 was 1.152 billion yuan, up 32.64% year-on-year, with a gross profit margin of 33.65% [1][12] - The company is expanding its production capacity with new projects, including a 30,000-ton dietary fiber project and a 15,000-ton crystalline fructose project, which are expected to contribute to sustained revenue and profit growth [1][11][28] Summary by Sections Financial Performance - In 2024, the company reported total revenue of 1.152 billion yuan, a 32.64% increase year-on-year, and a net profit of 246 million yuan, up 27.26% [1][12] - For Q1 2025, the company achieved revenue of 313 million yuan, a 24.27% increase year-on-year, and a net profit of 81.4 million yuan, reflecting a 52.06% growth [1][13] - The gross profit margin for 2024 was 33.65%, while for Q1 2025, it improved to 39.74% [1][13] Business Segments - The company’s main business segments include prebiotics, dietary fibers, healthy sweeteners, and other starch sugars. In 2024, the prebiotics segment generated 322 million yuan in revenue, a 25.43% increase, while the dietary fiber segment saw revenue of 624 million yuan, up 40.42% [2][21] - The healthy sweeteners segment, driven by increased demand for allulose in overseas markets, generated 156 million yuan, a 13.85% increase, with allulose accounting for 14.12% of total revenue [2][21] Expansion Projects - The company is actively advancing its "Functional Sugar Drying Expansion Project" and "Thailand Health Project," which are expected to enhance profitability. The functional sugar project aims to increase production capacity for isomaltulose and other products [3][25][26] - The Thailand production base project is in the planning stage and is expected to start construction in the second or third quarter of 2025, aiming to produce 12,000 tons of crystalline allulose and 7,000 tons of liquid allulose annually [4][26] Market Outlook - The global market for allulose has grown from 33 million USD in 2019 to 173 million USD in 2023, with a compound annual growth rate of 33.26%. It is projected to reach 545 million USD by 2030 [9][27] - The approval process for allulose as a new food ingredient in China is progressing, with significant policy support expected to boost the market further [9][27]
百龙创园:新产能快速爬坡,公司利润持续增长-20250501